Literature DB >> 19100669

Silicate nephrolithiasis after ingestion of supplements containing silica dioxide.

Jennifer E Flythe1, Jose F Rueda, Michael K Riscoe, Suzanne Watnick.   

Abstract

Silicate calculi are common in some mammals, such as dogs and sheep, but extremely rare in humans. We report a case of silicate calculi in a woman using oral over-the-counter Uncaria tomentosa, Digestive Advantage and FlexProtex supplements. All 3 contained the excipient silica dioxide. Stone analysis showed composition of 100% silicate. The nephrolithiasis promptly abated after discontinuation of the products containing silica, then returned when the patient restarted her supplements. This case emphasizes the importance of stone analysis when obvious causes of nephrolithiasis are unclear and highlights the concerns of using over-the-counter supplements without substantial oversight.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100669     DOI: 10.1053/j.ajkd.2008.10.042

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  A case of infection-associated antiproteinase-3-negative cytoplasmic antineutrophil cytoplasmic antibody pauci-immune focal necrotizing glomerulonephritis.

Authors:  Emmy K Bell; Sumant S Chugh; William J Cook
Journal:  Nephrol Dial Transplant       Date:  2010-06-21       Impact factor: 5.992

Review 2.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 3.  Animal models of naturally occurring stone disease.

Authors:  Ashley Alford; Eva Furrow; Michael Borofsky; Jody Lulich
Journal:  Nat Rev Urol       Date:  2020-11-06       Impact factor: 16.430

4.  The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits.

Authors:  Evan Barr-Beare; Vijay Saxena; Evann E Hilt; Krystal Thomas-White; Megan Schober; Birong Li; Brian Becknell; David S Hains; Alan J Wolfe; Andrew L Schwaderer
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.